Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Revenues:
Product sales	$ 50	$ 480	$ 530	$ 8,035
Sublicense fees		50,000		50,000
Total revenues	50	50,480	530	58,035
Cost of revenues:
Product sales	20	192	212	4,211
Total cost of revenues	20	192	212	4,211
Gross Margin	30	50,288	318	53,824
Operating expenses:
Research and development expenses	70,809	88,093	243,748	268,322
Selling, general and administrative expenses	60,826	426,465	191,614	738,185
Total operating expenses	131,635	514,558	435,362	1,006,507
Operating loss	(131,605)	(464,270)	(435,044)	(952,683)
Other income (expense)
Gain on debt conversion			15,220
Change in fair value of derivatives	15,096	(9,954)	37,750	(9,122)
Interest expense	(30,266)	(60,583)	(129,442)	(122,008)
Other income				450
Net loss	(146,775)	(534,807)	(511,516)	(1,083,363)
Preferred stock dividend	(8,097)	(4,250)	(22,753)	(12,706)
Net loss applicable to common shareholders	$ (154,872)	$ (539,057)	$ (534,269)	$ (1,096,069)
Basic and diluted net loss per share (in Dollars per share)	$ 0.00	$ (0.01)	$ (0.01)	$ (0.02)
Weighted average shares outstanding – basic and diluted (in Shares)	73,554,897	67,086,692	73,304,993	63,220,240